首页> 外文期刊>Review of quantitative finance and accounting >R&D expenditures and implied equity risk premiums
【24h】

R&D expenditures and implied equity risk premiums

机译:研发支出和隐含股权风险溢价

获取原文
获取原文并翻译 | 示例
           

摘要

This study investigates the relationship between research and development (R&D) expenditures and risk premiums implied in the costs of equity capital. We posit that R&D expenditures represent an information risk factor resulting from both information asymmetry about R&D between investors and managers and low-quality R&D reporting that impairs the coordination between investors and managers with respect to managers' investment decisions. Our results support our position by showing a positive association between R&D expenditures and implied equity risk premiums. From this research along with prior studies, investors can have better knowledge about the risky nature of R&D expenditures that drive up implied risk premiums and at the same time provide opportunities to earn excess returns in a short to long horizon. Accounting standard setters can benefit from this study's findings that R&D expenditures represent an off-balance-sheet risk factor and thus warrant reconsidering SFAS No. 2 for potential capitalization of R&D expenditures.
机译:本研究调查了研发(R&D)支出与权益资本成本中隐含的风险溢价之间的关系。我们认为,R&D支出代表了一种信息风险因素,这是由投资者和管理者之间关于R&D的信息不对称以及低质量的R&D报告(这会损害投资者和管理者之间关于管理者的投资决策的协调性)造成的。我们的结果通过显示研发支出与隐含股权风险溢价之间的正相关关系来支持我们的立场。从这项研究以及以前的研究中,投资者可以更好地了解研发支出的风险性质,这会增加隐含的风险溢价,同时又提供了在短期到长期内获得超额收益的机会。会计准则制定者可以从这项研究的发现中受益,因为研究与开发支出是表外风险因素,因此有必要重新考虑SFAS No. 2,以将研究与开发支出资本化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号